Navigation Links
ARIUS announces first quarter fiscal 2008 financial results
Date:4/11/2008

TORONTO, April 11 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced its financial and operational results for the first fiscal quarter of 2008, ended February 29, 2008.

"During the quarter, we continued to focus on advancing our antibody drugs efficiently and rapidly towards human clinical trials. Most significantly, we completed our pre-IND meeting with the US FDA for our lead CD44 Cancer Stem Program," said Dr. David Young, President and CEO of ARIUS. "We also presented new findings from our lead programs, including data from our CD9 Cancer Stem Cell program in collaboration with Dr. John Dick, a pioneer in the cancer stem cell field. Maintaining this momentum, five ARIUS abstracts have been selected for presentation in the upcoming AACR Annual meeting this month, demonstrating the scientific community's ongoing interest in our programs and the high quality of our research."

Program Updates:

CD44 Cancer Stem Cell Program

- Selected to present two CD44-focused posters at AACR the American

Association for Cancer Research (AACR) Annual Meeting held from

April 12-16, 2008 in San Diego, California.

- Held meeting with FDA to discuss plans for the upcoming

IND submission.

- Prepared to file a Phase I IND application and begin human

clinical trials for the CD44 Cancer Stem Cell program in 2008.

Trop-2 Signal Transduction Program

- Completed first toxicology studies.

- Selected to present a Trop-2-focused poster at AACR Annual

Meeting.

- Engaged Laureate Pharma Inc. for cGMP manufacturing of humanized

antibody for Phase 1 clinical supply. A cell line producing the

humanized anti-Trop-2 antibody was successfully transferred to

Laureate.

- Pr
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... VILLAGE, Nev. , Sept. 17, 2014  PDL BioPharma, ... by its independent registered accounting firm, Ernst & Young LLP ... resignation was confirmed in a letter delivered to the Company ... filed on September 16, 2014.  PDL has ... "We have received a number of inquiries on the ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... 17, 2014  The In Silico Drug Discovery Conference ... featured at the conference, which takes place at North ... and 4, 2014. Researchers, students, drug developers, business development ... following: KEYNOTE SPEAKERS ... School of Pharmacy Drug Discovery with Three ...
(Date:9/17/2014)... 2014 Shimadzu Scientific Instruments ... (2D-LC), which offers a powerful separation method ... system provides a new level of knowledge ... beneficial to scientists analyzing pharmaceutical impurities, proteins, ... , Comprehensive 2D-LC combines two independent separation ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... class of enzymes routinely used to synthesizing some of nature's ... a new way to expand on nature's chemical creativity to ... (Sept. 1) in the journal Science , a team ... at the University of Wisconsin-Madison , describes the discovery ...
... life sciences company with 120 Madison employees is bolstering ... of proteins in today's drug development market. , ,The ... Corp. 's recent acquisition of Sentigen Holding Corp., which ... Madison. , , The scientific opportunity , ,The ...
... summer, but for workers the lazy, hazy, crazy vacation days ... So now that we are all rested and relaxed, what ... , ,Well, actually neither workers or the workplace seem to ... conflict and strife between management and workers, real tensions exist ...
Cached Biology Technology:UW finds new path to anti-cancer agents 2UW finds new path to anti-cancer agents 3Invitrogen boosts drug development capability 2Workplace flexibility: Give and take or tug of war? 2Workplace flexibility: Give and take or tug of war? 3Workplace flexibility: Give and take or tug of war? 4Workplace flexibility: Give and take or tug of war? 5
(Date:9/17/2014)... A team of Spanish researchers have obtained the first ... a sixteenth century pig found at the site of ... that this ancient pig is closely related to today,s ... pigs were crossed with modern Iberian pigs. , The ... on evolutionary aspects of pig species, and particularly on ...
(Date:9/17/2014)... DC A team of researchers working on a Carnegie ... coral growth rates have plummeted 40% since the mid-1970s. ... an important role in this perilous slowdown. , ... facing coral reefs, the team compared current measurements of ... Barrier Reef with similar measurements taken more than 30 ...
(Date:9/17/2014)... social behavior by studying nonhuman mammals and primates, but ... their unusually large brains relative to their body size ... environment---not merely in a large population of cooperating creatures, ... setting of alliances and competitors. The same is true ... social carnivores, like hyenas and lions. , A new ...
Breaking Biology News(10 mins):Iberian pig genome remains unchanged after 5 centuries 2Coral growth rate plummets in 30-year comparison 2Being social: Learning from the behavior of birds 2
... Nov. 18, 2010 The 2010 Golf Atlanta charity golf ... aimed at finding better treatments and eventually a cure for ... 15, 2010, to the Crabapple Golf Club in Alpharetta, Ga., ... Genomics Research Institute (TGen), a non-profit biomedical research facility in ...
... For Immediate Release While scientists depend on ... long and frequently frustrating process. For one Scripps Research ... Ja, an assistant professor in the Department of Metabolism ... January, was recently awarded an unsolicited grant of $60,000 ...
... November 18, 2010 The Paul G. Allen Family ... and cellular engineering research. The Allen Distinguished Investigator Awards ... Washington, California, Massachusetts and New York. The grants ... years. "A year ago, I started ...
Cached Biology News:Golf Atlanta charity tournament raises $105,000 for TGen research 2New Scripps Florida scientist awarded pair of unconventional grants 2First Allen Distinguished Investigators named 2First Allen Distinguished Investigators named 3
... Laser Capture Microdissection (LCM) is the ... worldwide. Veritas Microdissection is the only instrument ... providing unmatched flexibility., UV Laser ... ,Ideal for non-soft tissues and capturing large ...
Hybridizer (220 V) For more information, please visit Dako' web-site. EU regulatory status: CE US regulatory status: IVD...
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
Biology Products: